Climb Global Solutions earnings were $18.6M for the trailing 12 months ending Dec 31, 2024, with 49.3% growth year over year. The latest CLMB earnings report on Dec 31, 2024 announced Q4 2024 earnings of $7.0M, up 28% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLMB reported annual earnings of $18.6M, with 51% growth. The next CLMB earnings date is Apr 29, 2025.
CLMB past earnings growth
How has CLMB's earnings growth performed historically?
Climb Global Solutions Earnings Reports & History FAQ
What were Climb Global Solutions's earnings last quarter?
On CLMB's earnings call on Invalid Date, Climb Global Solutions (NASDAQ: CLMB) reported Q4 2024 earnings per share (EPS) of $1.52, up 32.17% year over year. Total CLMB earnings for the quarter were $6.99 million. In the same quarter last year, Climb Global Solutions's earnings per share (EPS) was $1.15.
The next CLMB earnings call is Invalid Date. Add CLMB to your watchlist to be reminded of Climb Global Solutions's next earnings date.
What was CLMB's earnings growth in the past year?
As of Climb Global Solutions's earnings date in Invalid Date, Climb Global Solutions's earnings has grown 49.26% year over year. This is 65.93 percentage points higher than the US Electronics & Computer Distribution industry earnings growth rate of -16.66%. CLMB earnings in the past year totalled $18.61 million.
Is Climb Global Solutions profitable or losing money?
As of the last Climb Global Solutions earnings report, Climb Global Solutions is currently profitable. Climb Global Solutions's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $18.61 million, a 51.02% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.